BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 2132174)

  • 1. 5-Hydroxytryptamine-receptor subtypes.
    Brodde OE
    Clin Physiol Biochem; 1990; 8 Suppl 3():19-27. PubMed ID: 2132174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A nonclassical 5-hydroxytryptamine receptor positively coupled with adenylate cyclase in the central nervous system.
    Dumuis A; Bouhelal R; Sebben M; Cory R; Bockaert J
    Mol Pharmacol; 1988 Dec; 34(6):880-7. PubMed ID: 2849052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular effects of serotonin agonists and antagonists.
    Saxena PR; Villalón CM
    J Cardiovasc Pharmacol; 1990; 15 Suppl 7():S17-34. PubMed ID: 1702484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation by 5-HT1A receptors of the 5-HT2 receptor-mediated tachykinin-induced contraction of the rat trachea in vitro.
    Germonpré PR; Joos GF; Pauwels RA
    Br J Pharmacol; 1998 Apr; 123(8):1571-8. PubMed ID: 9605563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and classification of 5-HT1 receptor subtypes.
    Göthert M; Schlicker E
    J Cardiovasc Pharmacol; 1990; 15 Suppl 7():S1-7. PubMed ID: 1702482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotonin receptor-mediated activation of adenylate cyclase in the neuroblastoma NCB.20: a novel 5-hydroxytryptamine receptor.
    Conner DA; Mansour TE
    Mol Pharmacol; 1990 May; 37(5):742-51. PubMed ID: 2338946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Classification of serotonin receptors.
    Göthert M; Schlicker E
    J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S3-7. PubMed ID: 2446065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Central serotonin receptors. Principal fundamental and functional aspects. Therapeutic applications].
    Moulignier A
    Rev Neurol (Paris); 1994; 150(1):3-15. PubMed ID: 7801037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonin receptor subtypes: implications for psychopharmacology.
    Cowen PJ
    Br J Psychiatry Suppl; 1991 Sep; (12):7-14. PubMed ID: 1840764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological characterization of a neuronal receptor for 5-hydroxytryptamine in guinea pig ileum with properties similar to the 5-hydroxytryptamine receptor.
    Craig DA; Clarke DE
    J Pharmacol Exp Ther; 1990 Mar; 252(3):1378-86. PubMed ID: 2319473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin).
    Hoyer D; Clarke DE; Fozard JR; Hartig PR; Martin GR; Mylecharane EJ; Saxena PR; Humphrey PP
    Pharmacol Rev; 1994 Jun; 46(2):157-203. PubMed ID: 7938165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the neuroendocrine role of serotonin.
    Jørgensen HS
    Dan Med Bull; 2007 Nov; 54(4):266-88. PubMed ID: 18208678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacology of 5-hydroxytryptamine-1A receptors which inhibit cAMP production in hippocampal and cortical neurons in primary culture.
    Dumuis A; Sebben M; Bockaert J
    Mol Pharmacol; 1988 Feb; 33(2):178-86. PubMed ID: 2828913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological properties of the receptor(s) involved in the 5-hydroxytryptamine-induced contraction of the feline middle cerebral artery.
    Hamel E; Robert JP; Young AR; MacKenzie ET
    J Pharmacol Exp Ther; 1989 Jun; 249(3):879-89. PubMed ID: 2732950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cisapride and 5-hydroxytryptamine enhance motility in the canine antrum via separate pathways, not involving 5-hydroxytryptamine1,2,3,4 receptors.
    de Ridder WJ; Schuurkes JA
    J Pharmacol Exp Ther; 1993 Jan; 264(1):79-88. PubMed ID: 8093733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-hydroxytryptamine: considerations about discovery, receptor classification and relevance to medical research.
    Villalón CM; Terrón JA; Ramírez-San Juan E; Saxena PR
    Arch Med Res; 1995; 26(4):331-44. PubMed ID: 8555727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is there a relationship between serotonin receptor subtypes and selectivity of response in specific psychiatric illnesses?
    Montgomery SA; Fineberg N
    Br J Psychiatry Suppl; 1989 Dec; (8):63-9. PubMed ID: 2692641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The 5-HT1-like receptors mediating inhibition of sympathetic vasopressor outflow in the pithed rat: operational correlation with the 5-HT1A, 5-HT1B and 5-HT1D subtypes.
    Villalón CM; Centurión D; Rabelo G; de Vries P; Saxena PR; Sánchez-López A
    Br J Pharmacol; 1998 Jul; 124(5):1001-11. PubMed ID: 9692787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct activation by dopamine of recombinant human 5-HT1A receptors: comparison with human 5-HT2C and 5-HT3 receptors.
    Oz M; Zhang L; Rotondo A; Sun H; Morales M
    Synapse; 2003 Dec; 50(4):303-13. PubMed ID: 14556235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphoinositide system-linked serotonin receptor subtypes and their pharmacological properties and clinical correlates.
    Pandey SC; Davis JM; Pandey GN
    J Psychiatry Neurosci; 1995 May; 20(3):215-25. PubMed ID: 7786883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.